National Healthcare Corporation reports Q3 net revenues of $382.7 million and net income of $39.2 million

Reuters
Nov 07, 2025
<a href="https://laohu8.com/S/NHC">National Healthcare</a> Corporation reports Q3 net revenues of $382.7 million and net income of $39.2 million

National Healthcare Corporation reported net revenues of $382.7 million for the third quarter ended September 30, 2025, up 12.5% from $340.2 million in the same period of 2024. The increase was driven by an 8.7% rise in same-facility net revenues and the acquisition of White Oak Management on August 1, 2024. GAAP net income attributable to NHC was $39.2 million, compared to $42.8 million a year earlier. Adjusted net income, excluding unrealized gains and losses in marketable equity securities and other non-GAAP adjustments, was $24.7 million, up 24.3% from $19.9 million in the prior year. GAAP diluted earnings per share were $2.50, with adjusted diluted earnings per share at $1.58.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. National Healthcare Corporation published the original content used to generate this news brief via Business Wire (Ref. ID: 20251106632342) on November 07, 2025, and is solely responsible for the information contained therein.

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10